BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23516885)

  • 1. [Comparative evaluation of the efficiency of different magnetic resonance imaging procedures in the recognition of local recurrence of prostate cancer: preliminary results].
    Kapustin VV; Gromov AI; Koshurnikov DS
    Vestn Rentgenol Radiol; 2012; (5):48-51. PubMed ID: 23516885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
    Silverman JM; Krebs TL
    AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer.
    Nishida K; Yuen S; Kamoi K; Yamada K; Akazawa K; Ito H; Okihara K; Kawauchi A; Miki T; Nishimura T
    Acta Radiol; 2011 Feb; 52(1):120-6. PubMed ID: 21498337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
    Liauw SL; Pitroda SP; Eggener SE; Stadler WM; Pelizzari CA; Vannier MW; Oto A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):378-84. PubMed ID: 22717242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
    Kapustin VV
    Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of suspected soft tissue lesion in the prostate bed after radical prostatectomy using 3T multiparametric magnetic resonance imaging.
    Cha D; Kim CK; Park SY; Park JJ; Park BK
    Magn Reson Imaging; 2015 May; 33(4):407-12. PubMed ID: 25527395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Capabilities of diffusion-weighted magnetic resonance imaging to evaluate the efficiency of treatment for prostate cancer].
    Ridén TV; Revizonskaia AV
    Vestn Rentgenol Radiol; 2014; (2):38-44. PubMed ID: 25272722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
    Wu LM; Xu JR; Gu HY; Hua J; Zhu J; Chen J; Zhang W; Hu J
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):252-64. PubMed ID: 23313568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience.
    Giannarini G; Nguyen DP; Thalmann GN; Thoeny HC
    Eur Urol; 2012 Mar; 61(3):616-20. PubMed ID: 22137601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
    Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
    Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
    Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
    Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.